Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arvinas (ARVN) Research & Development: 2017-2025

Historic Research & Development for Arvinas (ARVN) over the last 9 years, with Sep 2025 value amounting to $64.7 million.

  • Arvinas' Research & Development fell 25.55% to $64.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $307.4 million, marking a year-over-year decrease of 14.63%. This contributed to the annual value of $348.2 million for FY2024, which is 8.30% down from last year.
  • Latest data reveals that Arvinas reported Research & Development of $64.7 million as of Q3 2025, which was down 5.69% from $68.6 million recorded in Q2 2025.
  • In the past 5 years, Arvinas' Research & Development ranged from a high of $103.4 million in Q2 2023 and a low of $34.9 million during Q1 2021.
  • Over the past 3 years, Arvinas' median Research & Development value was $86.9 million (recorded in 2024), while the average stood at $86.6 million.
  • Its Research & Development has fluctuated over the past 5 years, first spiked by 90.89% in 2022, then dropped by 26.79% in 2025.
  • Arvinas' Research & Development (Quarterly) stood at $61.9 million in 2021, then surged by 58.80% to $98.3 million in 2022, then decreased by 3.15% to $95.2 million in 2023, then decreased by 12.50% to $83.3 million in 2024, then fell by 25.55% to $64.7 million in 2025.
  • Its Research & Development was $64.7 million in Q3 2025, compared to $68.6 million in Q2 2025 and $90.8 million in Q1 2025.